Marston Health Reports

Your Guide to Health, Nutrition, and Wellness

As the prevalence of liver disease continues to rise across the world, the growing number of people impacted by cirrhosis, liver cancer, and nonalcoholic fatty liver disease, is the focus of more than 1,700 of the world’s leading liver disease experts who are meeting here in Prague, Czech Republic, this week to share innovative research that aims to identify and enhance prevention techniques and improve outcomes.

Continuing Advancements in Liver Disease and Transplantation

May 25, 2017 - As the prevalence of liver disease continues to rise across the world, the growing number of people impacted by cirrhosis, liver cancer, and nonalcoholic fatty liver disease, is the focus of more than 1,700 of the world’s leading liver disease experts who are meeting here in Prague, Czech Republic, this week to share innovative research that aims to identify and enhance prevention techniques and improve outcomes.

Dr. Michael Charlton, Intermountain Medical Center Transplant Program in Salt Lake City, addresses the International Liver Transplant Society Conference

“Every year, this meeting brings together the brightest minds in liver transplantation and encourages the transition of knowledge from one country to another,” said Michael Charlton, MD, associate director of the Intermountain Medical Center Transplant Program, who is current president of the International Liver Transplantation Society. “Over the years I’ve watched this global exchange of best practice information and evidence-based medicine on how to provide the very best possible outcomes for patients. All of the research presented here has very practical applications for caregivers throughout the world.”

The 2017 International Joint Congress of the International Liver Transplantation Society (ILTS), the European Liver and Intestine Transplant Association (ELITA), and the Liver Intensive Care Group of Europe (LICAGE) is being held May 24-27 in Prague.

One of the most anticipated elements of the meeting is the presentation of 10 of the world’s most innovative and high-impact research studies. This includes:

- Identifying patients who will do better or worse after transplant for liver cancer — and, with this knowledge, where caregivers must focus their attention in the future.

- Being able to expand the potential donor pool of organs available for liver transplantation by using newly developed tests and technologies like ex-vivo perfusion.

- Identifying patients with severe alcoholic liver disease who might be suitable for liver transplantation, but who aren’t current candidates.

- The impact of treating patients with the most severe liver disease due to hepatitis C before transplant — with a focus on preventing the need for transplants when possible while not committing others to MELD (Model for End-Stage Liver Disease) purgatory.

"This meeting brings together all of the leaders from transplant programs throughout the world with the objective of improving the way we help our patients live the healthiest life possible.” — Michael Charlton, MD, Intermountain Medical Center Transplant Program

Research centers presenting late-breaking research include Intermountain Medical Center in Salt Lake City; King’s College Hospital in London; University Hospital RWTH in Aachen, Germany; Anan Medical Center in Seoul, Korea; and St. James Hospital in Dublin, Ireland.

“This meeting is a critically important component in the voice for research,” said hepatologist Richard Gilroy, MD, medical director of the Intermountain Medical Center Liver Transplant Program. “It brings together all of the leaders from transplant programs throughout the world with the objective of improving the way we help our patients live the healthiest life possible.”

This year’s conference will be the largest in history and includes doctors, nurses, anesthesiologists, surgeons, infectious disease physicians, radiologists, and several other subspecialties from more than 80 countries who treat liver disease in all its facets.


Contact: Jess Gomez
              Intermountain Medical Center
              801-507-7455
              email


 

AP Health

Health Headlines

  • Trump's move may nudge holdout GOP states to expand Medicaid
    WASHINGTON (AP) — In an ironic twist, the Trump administration's embrace of work requirements for low-income people on Medicaid is prompting lawmakers in some conservative states to resurrect plans to expand health care for the poor.
  • Do e-cigarettes help or harm? Report says not clear yet
    WASHINGTON (AP) — Electronic cigarettes could be a boon to public health or a major liability, depending on whether they help Americans quit smoking or encourage more young people to try traditional cigarettes, a new report concludes.
  • Trump's global gag rule goes far beyond abortion, groups say
    JOHANNESBURG (AP) — President Donald Trump's dramatic expansion of a ban on U.S. funding to foreign organizations that promote or provide abortions has left impoverished women around the world without treatment for HIV, malaria and other diseases, health groups say, calling it "devastating" because Trump went where no administration had gone before.
  • Philadelphia wants safe injection sites to help opioid fight
    PHILADELPHIA (AP) — Philadelphia wants to become the first U.S. city to allow supervised drug injection sites as a way to combat the opioid epidemic.
  • Kenyans accuse largest hospital of rape, abuse of patients
    NAIROBI, Kenya (AP) — Hundreds of Kenyans held a peaceful demonstration at the country's largest public hospital on Tuesday to demand that management act on allegations of rape and sexual harassment of patients.
© 2017 Holeigh J. Skyler Foundation -- All Rights Reserved.

Search

Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.